Navigation Links
Pharmaceutical Direct to Consumer Advertising on The American Law Journal

PHILADELPHIA, Jan. 17 /PRNewswire/ -- In the last decade, the number of consumers taking antidepressants has more than doubled, with a staggering 4000% increase in the diagnosis of bipolar disorder in children in that time.  Doctors wrote 164 million prescriptions for antidepressants in 2008. Pharmaceutical companies spend billions of dollars on direct to consumer pharmaceutical advertising psychiatric drugs. Is there a connection? And when a patient experiences harm from a drug, does direct to consumer advertising play a role in litigation?

Monday January 18 live from 7:00-8:00 p.m. EST on the Philadelphia CNN-News affiliate WFMZ-TV and streaming online at, The American Law Journal presents "Ask Your Doctor If 'x' is Right for You— Does Drug Advertising Help or Hurt the Consumer?" Philadelphia-based lawyers and a prominent pain physician address the legal, medical and social implications of direct to consumer drug advertising. Former New Jersey prosecutor Christopher Naughton, a legal commentator and 20-year legal broadcasting veteran, hosts the program.

On the panel representing consumers and pharmaceutical whistleblowers in nationwide, complex pharmaceutical litigation and recent landmark pharmaceutical settlements is Stephen Sheller, Esq. of the law firm of Sheller, P.C.. Raymond Williams, Esq. of DLA Piper brings his expertise defending top-tier pharmaceutical companies in high-profile cases to the conversation. Joining Sheller and Williams is physician Frank J.E. Falco, M.D., CEO of the Mid-Atlantic Spine & Pain Physicians and Vice President of the American Society of Interventional Pain Physicians. The program will address both informational and product drug advertising with an emphasis on the rapid growth of marketing and prescribing antidepressant and antipsychotic drugs.

Despite health concerns and the increase in lawsuits involving antipsychotic drugs, "we're seeing more drug advertising with 'if you're antidepressant isn't doing enough for you' ads," says Sheller, "and with the FDA approving the use of antipsychotics in children, it's becoming a huge moral question."

The American Law Journal is a weekly talk-feature program that addresses consumer, business and constitutional law. The program is seen throughout the Philadelphia tri-state region, streams live, and is available for download. Free links for downloads are available by request from while the program website is under renovation. Next week on The American Law Journal: "The Lawyer, the Client, the Insurance Adjuster & the Judge."

Available Topic Experts: For information on the listed expert(s), click appropriate link.

Christopher Naughton   |

Stephen  Sheller, Esq.   |

SOURCE The American Law Journal

SOURCE The American Law Journal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):